You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. IN VITRO DRUG SENSITIVITY TESTING OF MARROW METASTASES

    SBC: BIS LABORATORIES            Topic: N/A

    HUMAN TUMOR CLONOGENIC ASSAYS (HTCA'S) ARE USED TO TEST TUMOR SPECIMENT IN VITRO AGAINST CHEMOTHERAPEUTIC DRUGS. CURRENTLY, USE OF HTCA'S IS LIMITED TO TUMOR SPECIMENS OBTAINED AT DIAGNOSIS OR AT OVERT RELAPSE. AN IDEAL SITUATION WOULD BE TO TEST METASTATIC CELLS PRIOR TO RELAPSE BEFORE DRUG RESISTANCE IS A FACTOR. THIS SITUATION IS FEASIBLE BY OBTAINING SMALL NUMBERS OF TUMOR CELLS FROM THE BONE ...

    SBIR Phase II 1996 Department of Health and Human Services
  2. NEXT GENERATION SOFTWARE FOR GROUP SEQUENTIAL ANALYSIS

    SBC: INSIGHTFUL CORPORATION            Topic: N/A

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  3. LIPOSOMES FOR DELIVERY OF DRUGS TO HAIR-FOLLICLE CELLS

    SBC: ANTICANCER, INC.            Topic: N/A

    THERE IS A NEED TO STIMULATE HAIR GROWTH FOR VARIOUS CONDITIONS OF ALOPECIA. IT IS ASSERTED THAT TO ACHIEVE HAIR GROWTH STIMULATION, BIOLOGICALLY ACTIVE COMPOUNDS MUST BE DELIVERED INSIDE HAIR FOLLICLE CELLS, AND THAT THE OPTIMAL WAY TO IDENTIFY ACTIVE COMPOUNDS AND METHODS OF THEIR DELIVERY IS TO USE AN IN VITRO SYSTEM. ACTIVE COMPOUNDS IN PRINCIPLE COULD BE ALSO USED TO CAUSE DESIRED IN HAIR COL ...

    SBIR Phase II 1996 Department of Health and Human Services
  4. Semiautomatic, Quantitative Analysis of Funds

    SBC: APPLIED SCIENCES LABORATORY, INC.            Topic: N/A

    N/A

    SBIR Phase II 1996 Department of Health and Human Services
  5. NEW X RAY TUBE FOR CT SCANNERS

    SBC: AXR, INC.            Topic: N/A

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  6. Accurate Characterization of Composite Strength Through Empirical and Progressive Damage Methods

    SBC: Biosearch Technologies, Inc            Topic: N/A

    N/A

    SBIR Phase II 1996 Department of Health and Human Services
  7. COMBINATORIAL CHEMISTRY ON ASPECT SUPPORTS

    SBC: Biosearch Technologies, Inc            Topic: N/A

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  8. Human Iduronidase Hurler syndrome expression in plant

    SBC: CROPTECH CORPORATION            Topic: N/A

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  9. Perfusion Devices for Cell Analysis

    SBC: Grace Bio-oncology Laboratoryo            Topic: N/A

    The plan is to test the hypothesis that sufficient porosity can be created in thin tissue sectionsto move reactants dynamic perfusion. This is expected to require control of the freezing rate inlyophilization and use of proprietary microporous film technology. At present, reagents are introducedin tissue sections by static diffusion. The vertical flow of fluid through "microchannelled" tissue byme ...

    SBIR Phase II 1996 Department of Health and Human Services
  10. Human Monoclonal Antibody to Respiratory Syncytial Virus

    SBC: IDEC PHARMACEUTICALS CORPORATION            Topic: N/A

    Passive immunotherapy has been shown to be an effective method for controlling RSV infection. The virus envelope fusion (F protein) represents an ideal target for passive immunotherapy because antibodies to this protein typically bind to and neutralize both of the two clinical subgroups of this virus, A and B. In addition, antibodies to the F protein have been shown to provide protection in animal ...

    SBIR Phase II 1996 Department of Health and Human Services
US Flag An Official Website of the United States Government